Induction of hypertrophy and inhibition of apoptosis may be important mechanisms contributing to increased airway smooth muscle (ASM) mass in asthma.
Introduction
Increased smooth muscle mass has been repeatedly documented in asthmatic subjects (3, 11, 29, 33, 34) , but the mechanisms responsible for the increased mass are unclear. The amount of both airway smooth muscle and smooth muscle associated matrix is greater with increased duration of asthma and may be an important determinant of the severity of airways responsiveness (3, 15) , yet the functional alterations in airway smooth muscle in asthma are uncertain (29, 34) . When bronchial segments from asthmatics have been studied in vitro, the majority of studies have shown no change in mechanical properties, although isolated cells from asthmatics show a higher velocity of shortening (16) . Tracheal tissue offers some advantages in studies of ASM behavior in that the muscle is more uniform in orientation and less matrix elements are present. The only study of asthmatic trachea, in severe asthma, showed a non-specific increase in force generation, suggesting increased contractility.
However, force was normalized to tissue weight, not muscle mass (1) , thus the changes could have been a reflection of increased muscle.
Cardiotrophin-1 (CT-1), a member of the IL-6 family, was initially defined as a factor that has the capacity to induce cardiac myocyte hypertrophy (26) . Further study showed that CT-1 caused both enhanced survival and hypertrophy of differentiated cardiac muscle cells, and inhibited cardiac myocyte apoptosis following serum deprivation or cytokine stimulation (25, 30, 36, 37, 40) . CT-1, acting through the gp130 receptor common to the IL-6 family, has been reported to be critical in the induction of hypertrophy in response to biomechanical overload and is overexpressed in cardiomyopathy, as part of a panel of "fetal" genes induced in response to damage (14, We have demonstrated that CT-1 is detected in abundance in freshly isolated and minced normal adult human lung, and is expressed in both fetal and adult human primary cultured bronchial smooth muscle cells (HBSMC), predominantly in synthetic phenotypes. CT-1 induces a significant increase in HBSMC size as judged by protein/DNA ratio and flow cytometry, and reduces the apoptosis induced both by serum deprivation and by Fas antibody/TNF-treatment in HBSMC (38) .
We postulated that, in the tissue milieu, CT-1 would also increase airway smooth muscle mass and thus alter mechanical properties. To test these hypotheses, two protocols were used: initially, matched pairs of guinea pig airway explants were treated with or without CT-1 to determine structural changes. Secondly, in vitro smooth muscle function was evaluated. 
Material and Methods

Animals
Female Duncan-Hartley adult guinea pigs, 500-600g in weight, were used in this study, which was approved by the Biosafety and Animal Research Committee of the University of British Columbia.
Protocol 1: structural effects of CT-1 on explanted trachea
Explanted trachea. Tracheal ring explants were prepared as previously described from our laboratory (12) , and matched pairs of guinea pig airway explants were used for the study. Briefly, the trachea was isolated and all connective tissue and visible blood vessels were removed. Six to eight tracheal rings, 2.5-3mm in width, were cut from each animal and randomly chosen rings were placed individually into 12-well culture plates containing 1ml of CRML-1066 medium supplemented with 10% FBS, 2 mM glutamine, 5 µg/ml insulin, 0.25 µg/ml fungizone reagent, 100 units/ml of penicillin and 100 µg/ml streptomycin. Within each group, one ring served as the control, while the remaining rings were exposed to CT-1 ( 0.2, 1 or 5ng/ml). Tissue culture plates were placed on a tray in a controlled atmosphere chamber which was flushed with a mixture of 45% O 2 , 50% nitrogen and 5% CO 2 at a flow rate of 4 l/min for 15min. The chamber was then placed in a 37 0 C incubator on a rocking platform set at 10 cycles/min so that the tracheal lumen was intermittently exposed to media and gas mixture. The chamber was flushed with fresh gas mixture every 24 hours. The media and CT-1 were changed every 48h, and explants were cultured for 7 days. Airway smooth muscle morphometry. The method used was based on a protocol established in our laboratory (31) , with measurements on both circumferential and axial muscle profiles using different fixation techniques and section thickness. Different animals were used for axial (n = 6) and circumferential sections (n = 3). Axial muscle profiles were obtained by longitudinal sectioning of tracheal rings fixed at reference length [the length at which isometric force was measured]. Each of the tracheal rings was opened by cutting through the cartilage, and then individually suspended in glass jars containing a solution of 2.5% glutaraldehyde in 0.1M sodium cacodylate buffer, using suture thread and a weight conforming to preload at L max (0.8 -1.2 g). After fixation, the strips were dehydrated in a graded series of concentrations of isopropyl alcohol, and embedded in glycol methacrylate (JB-4) with the strips oriented such that the muscle was cut in axial cross-section. Two µm serial sections were cut on a JB-4 microtome (JB-4 Type Sorvall Microtome; Ivan Sorvall Inc, Newtown, CT), using glass knives. Every 20 th section was mounted on glass slides and numbered until approximately 1mm of smooth muscle had been sectioned. Sections were stained with Toluidine Blue-O. To obtain circumferential muscle profiles, tracheal rings were fixed at reference length as above using 10% buffered formalin, and paraffin embedded so that the strips were cut in cross-section. Five µm sections were cut onto glass slides and stained with haematoxylin and eosin Basement membrane length and the subtended smooth muscle bundle area were traced on axial sections using Bioquant (BQ) system software (R&M Biometrics Inc., Nashville, TN), as previously described, at a final magnification of X250 (3, 31) .
The proportion of smooth muscle in the wall sections was also quantified by projecting a 
Protocol 2: functional effects of CT-1 on airway smooth muscle
In vitro organ bath studies were carried out seven days after explant culture with or without CT-1(10ng/ml) to characterize mechanical properties as previously described (12, 23) . To minimize bias the operator did not know the treatment of the tissues. C. Indomethacin (2 µM) was added to the KH reservoir and was present for the duration of the experiment to inhibit prostaglandin synthesis and thus to stabilize muscle intrinsic tone (12) . The weight of the tissue was incorporated into a balancing current in the electronic circuit in order to achieve zero tension. The initial length of the muscle was measured with an optical micrometer to an accuracy of 0.01 mm. All subsequent changes in length were referenced to this value so that changes in length could be calculated. Each airway ring was slowly stretched three times by loads that determined optimal length during preliminary experiments, and then allowed to equilibrate in the organ bath with no load for 1 h, with fresh KH solution rinses every 15 minutes. After equilibration, passive, isometric and isotonic lengthtension relationships were obtained (12, 23) .
Passive length-tension relationship. Measurements of passive tension were made by stretching the muscle and recording the tension. The stretching preloads were performed at graded loads between 0 and 2.5 g. At each length, stable resting tension was recorded (4, 5, 12, 23) .
Isometric and isotonic preloaded contraction. Muscle contractions were elicited
by acetylcholine (10 -5 M). Measurement of isometric force was first made at lengths
below the level at which passive tension was first detected. A small preload was then applied to the strip to stretch it, and the length was recorded once it stabilized. An isometric contraction with this preload was performed by maintaining the airway length constant during Ach addition. Once the force returned to baseline at each preload, an isotonic contraction was elicited and the length change measured. At each preload, before isometric or isotonic stimulation, the baths were rinsed three times over ten minutes, and the strips were allowed to relax to their pre-stimulated baseline tone.
Complete isometric and isotonic length-tension relationships were obtained by serially increasing the smooth muscle length to 10-20% more than the length at which maximal force occurred. From the isometric force-length data, L max was determined as the length at which maximal isometric force (F max ) occurred. In the instances when the maximal force at two lengths was similar, the shorter of the two lengths was chosen (4, 5, 12, 23) .
Phamacodynamic-studies of ASM responsiveness. After the full length-tension relationship was determined, the muscle strips were allowed to equilibrate in the organ bath with no load for 1 hour, and then the strips were re-set at L max . All of the contractile and relaxation curves were performed at L max . A cumulative concentration-effect relationship (CCER) to histamine (10 -9 to 10 -4 M) was performed, and the effective concentration that produced 50% of the maximal response (EC50) was subsequently determined. Thereafter, a relaxation CCER to isoproterenol (10 -9 to 10 -4 M) was . The EC50 was calculated as previous described (27) .
Statistical analysis
All values are reported as mean ± SE. ANOVA or paired t tests were used to determine significance. P values < 0.05 were considered significant. To further evaluate whether the changes in smooth muscle mass in CT-1 (5 ng/ml) treated airways were due to an increase in cell size or number, or to an increase in the amount of extracellular matrix, we assessed the muscle bundles at a final magnification of X1250 (Fig. 2B) . The muscle cytoplasm/nuclei area fraction in CT-1 treated airways was 130.6 ± 7.7% of the control in axial cross sections (P < 0.05) and (Fig. 2B ).
Results
Protocol 2: functional effects of CT-1 on airway smooth muscle
Effects of CT-1 on airway smooth muscle passive length-tension characteristics:
Passive tension measurements of the muscle are illustrated in Fig. 3 . At all lengths,
CT-1 treated tissues generated higher passive tensions when compared with controls ( fig. 3 A) . After treating the airway trachea with CT-1 (10ng/ml) for 7 days, there was a decrease in the length relative to Lmax at all passive loads as compared with the controls ( fig. 3A) . At L max , passive tension generated by CT-1 treated groups was 1.72 ± 0.12g versus 1.0 ± 0.1 g for controls, n = 5, P < 0.05 ( fig. 3B ).
Effects of CT-1 on airway smooth muscle isometric stress:
Treatment of airway explants with CT-1 for 7 days induced a decrease in maximal Ach-induced isometric stress, 0.39 ± 0.1 in CT-1 treated group versus 0.77 ± 0.15, P <0.05, (Fig. 4) . The maximal isometric force to histamine was also significantly reduced in the CT-1 treated groups versus control groups (1.09 ± 0.79 in CT-1 treated tissues versus 1.51 ± 0.85 in control, n =5, P = 0.02) (fig. 4) . (Fig. 5 ). Data were missing for one pair owing to equipment malfunction.
Effects of CT-1 on
Effect of CT-1 on airway smooth muscle relaxation responses to isoproterenol.
Mean cumulative concentration effect curves to isoproterenol are shown Fig. 6A .
Isoproterenol produces concentration-dependent and cumulative isometric relaxation in guinea pig tracheal strips pretreated with histamine. After treatment of the explant with CT-1 (10ng/ml) for 7 days, isoproterenol-induced relaxation was significantly reduced.
The relaxation curve shifts to the right, which indicates that CT-1 treated tissues are less sensitive to isoproterenol as compared with controls (Fig. 6A ). Maximal relaxation, induced by addition of 10 -4 M papaverine and 10 -3 M EDTA, was not different from controls. Figure 6B shows the sensitivity to isoproterenol expressed as EC50 (the concentration required to give 50% of maximal response).
Morphometric Analysis: The area of smooth muscle, % total axial area, was significantly increased in CT-1 treated tissues versus controls, control 14.5 ± 1.30, CT 17.6 ± 1.40, similar results to protocol 1. This result demonstrates that CT-1 reproducibly increases airway smooth muscle mass, at a concentration two fold higher than the maximal used in protocol one. We employed an explant model developed in our laboratory (12) . Our prior experience with 72h or more of culture with PDGF [10ng/ml], histamine [0.1 mM], LTD4
[1uM] and TNF [0.1ug/ml] indicated that cytokines and mediators of asthma known to induce smooth muscle proliferative or functional changes in isolated cells do not do in airway explants, illustrating the selectivity and novelty of our results (17) . We compared two morphometric methods that provide different orientations of the airway smooth muscle, including axial cross-sectional profiles and circumferential profiles of smooth muscle, since muscle orientation plus methodological differences in preparation has been reported to result in a wide variation in the assessment of muscle mass (31, 32).
Although we reproducibly detected the increased muscle mass and hypertrophy in both sections, the matrix changes after CT-1 treatment were only detected in the axial cross- Although increased smooth muscle in asthmatic airways has been found repeatedly, the mechanism for the increase in cell size is uncertain has not been well defined. A recent report suggest human bronchial smooth muscle cell hypertrophy is secondary to cell cycle arrest (39) , however in prior experiments we have not observed an effect of CT-1 on cell cycle [ (38) and unpublished data]. Moreover activation of the GP130 receptor has been reported to induce cardiac myocyte hypertrophy both in vivo and in vitro (10, 37) . Further reports have shown that the JAK-STAT pathway, especially the STAT3-mediated pathway, appears to be essential in the induction of cardiac myocyte hypertrophy through gp130 (13, 14) . This study is the first to demonstrate that CT-1, which acts through a GP130/LIF receptor heterodimer, has the ability to induce airway smooth muscle hypertrophy in the tissue milieu, and that the hypertrophy is Given that there is more airway smooth muscle in asthma of long duration, greater active force generation has been proposed to exist simply due to the increased muscle mass (1, 7, 8, 29) . However, muscle contractility and tissue elastance are also influenced by cytokines, matrix-degrading enzymes, and other inflammatory mediators present in the airways of asthmatic subjects (19-21, 29, 35) . Our study demonstrates arranged radically can cause smooth muscle shortening to be limited (18, 19). Our study demonstrates at three preloads (0.25, 0.5, 0.80g), that the isotonic shortening tended to be lower in the CT-1 treated group, although not significant possibly due to the loss of a data pair through equipment malfunction. As discussed above, a reduction in the amount of shortening could be caused by matrix deposition, or to smooth muscle contractile element changes.
Structural changes in the airway wall do not necessarily imply airways hyper responsiveness. Indeed some data suggest that increased wall thickness may serve to limit airway narrowing as illustrated by the report of Niimi and colleagues (22). In addition, airway smooth muscle may contribute to airway hyperresponsiveness not only by its increased ability to shorten, but also by an impairment of its ability to relax (2, 6).
In our study, relaxation induced by a single pharmacological agent has been investigated. CT-1 treated tissues have less sensitivity to isoproterenol when compared with controls, but there was no effect on the maximal relaxation response. This result may be due to the effect of several factors, such as 2 adrenergic receptor dysfunction induced by CT-1, matrix deposition or changes in smooth muscle contractile phenotype, and requires more study.
In summary, we have demonstrated that CT-1 increases airway smooth muscle mass via both increased myocyte hypertrophy and matrix deposition in airway explants, alters airway smooth muscle mechanical proprieties, and reduces isoproterenol-induced airway smooth muscle relaxation. Our findings provide data for modeling, and further study of, the mechanical consequences of the structural changes of airways found in asthma. Experimental protocol is the same as in (A). Muscle cell size and number and matrix area within muscle bundles were assessed by point counting at a magnification of X1250. See methods for more details. Data are reported as the mean ± SE, comparing 5 ng/ml CT-1 with control. n = 6 (axial cross-section), n = 3 (circumferential section), * P < 0.01, ** P < 0.05. Value are mean ± SEM, n =5. (B) The concentration required to give 50% of maximal
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